Fecal microbiota transplantation in inflammatory bowel disease: the quest for the holy grail - PubMed (original) (raw)
Review
. 2016 Nov;9(6):1360-1365.
doi: 10.1038/mi.2016.67. Epub 2016 Jul 27.
Affiliations
- PMID: 27461176
- DOI: 10.1038/mi.2016.67
Free article
Review
Fecal microbiota transplantation in inflammatory bowel disease: the quest for the holy grail
B Pigneur et al. Mucosal Immunol. 2016 Nov.
Free article
Abstract
Inflammatory bowel disease (IBD) is due to an aberrant immune response toward luminal antigens, probably commensal bacteria, in genetically susceptible subjects and is also influenced by environmental factors. An imbalanced intestinal microbiota known as "dysbiosis," characterized by an increased proportion of pro-inflammatory microorganisms and a decreased proportion of anti-inflammatory microorganisms, has been repeatedly observed in IBD and is now recognized as a key factor in the gut inflammatory process. Fecal microbiota transplantation (FMT) has gained interest as a novel treatment option in IBD. The goal of FMT in IBD is not only to correct the dysbiosis, but also to restore a normal dialog between the host immune system and the microbiota. Data are still scarce, but the results of the first studies suggest that FMT could be a promising therapy in IBD. More studies are needed to define the best indications, optimal timing, frequency, mode of delivery, and the optimal donor for each patient.
Comment in
- Pretreatment with antibiotics may enhance the efficacy of fecal microbiota transplantation in ulcerative colitis: a meta-analysis.
Keshteli AH, Millan B, Madsen KL. Keshteli AH, et al. Mucosal Immunol. 2017 Mar;10(2):565-566. doi: 10.1038/mi.2016.123. Epub 2016 Dec 21. Mucosal Immunol. 2017. PMID: 28000680 No abstract available.
Similar articles
- Role of fecal microbiota transplantation in inflammatory bowel disease.
D'Odorico I, Di Bella S, Monticelli J, Giacobbe DR, Boldock E, Luzzati R. D'Odorico I, et al. J Dig Dis. 2018 Jun;19(6):322-334. doi: 10.1111/1751-2980.12603. Epub 2018 May 29. J Dig Dis. 2018. PMID: 29696802 Review. - Any Future for Fecal Microbiota Transplantation as Treatment Strategy for Inflammatory Bowel Diseases?
Kump P, Högenauer C. Kump P, et al. Dig Dis. 2016;34 Suppl 1:74-81. doi: 10.1159/000447379. Epub 2016 Aug 22. Dig Dis. 2016. PMID: 27548724 - Patients' views on fecal microbiota transplantation: an acceptable therapeutic option in inflammatory bowel disease?
Zeitz J, Bissig M, Barthel C, Biedermann L, Scharl S, Pohl D, Frei P, Vavricka SR, Fried M, Rogler G, Scharl M. Zeitz J, et al. Eur J Gastroenterol Hepatol. 2017 Mar;29(3):322-330. doi: 10.1097/MEG.0000000000000783. Eur J Gastroenterol Hepatol. 2017. PMID: 27879485 - Faecal Microbiota Transplantation in Inflammatory Bowel Disease: Current Concepts and Future Challenges.
Zatorski H, Nakov R. Zatorski H, et al. Curr Drug Targets. 2020;21(14):1440-1447. doi: 10.2174/1389450121666200602125507. Curr Drug Targets. 2020. PMID: 32484770 Review. - Fecal Microbiota Transplantation in Inflammatory Bowel Disease.
Reinisch W. Reinisch W. Dig Dis. 2017;35(1-2):123-126. doi: 10.1159/000449092. Epub 2017 Feb 1. Dig Dis. 2017. PMID: 28147375 Review.
Cited by
- Fecal Microbiota Transplant in Two Ulcerative Colitis Pediatric Cases: Gut Microbiota and Clinical Course Correlations.
Quagliariello A, Del Chierico F, Reddel S, Russo A, Onetti Muda A, D'Argenio P, Angelino G, Romeo EF, Dall'Oglio L, De Angelis P, Putignani L, All The Other Fmt Opbg Committee Collaborators. Quagliariello A, et al. Microorganisms. 2020 Sep 27;8(10):1486. doi: 10.3390/microorganisms8101486. Microorganisms. 2020. PMID: 32992653 Free PMC article. - Inter-kingdom effect on epithelial cells of the N-Acyl homoserine lactone 3-oxo-C12:2, a major quorum-sensing molecule from gut microbiota.
Landman C, Grill JP, Mallet JM, Marteau P, Humbert L, Le Balc'h E, Maubert MA, Perez K, Chaara W, Brot L, Beaugerie L, Sokol H, Thenet S, Rainteau D, Seksik P, Quévrain E; Saint Antoine IBD Network. Landman C, et al. PLoS One. 2018 Aug 29;13(8):e0202587. doi: 10.1371/journal.pone.0202587. eCollection 2018. PLoS One. 2018. PMID: 30157234 Free PMC article. - Effects of Different Feed Additives on Intestinal Metabolite Composition of Weaned Piglets.
Zhao M, Zhang J, Liu F, Luo L, Wei M, Ye Y, Yangzom C, Shang P. Zhao M, et al. Metabolites. 2024 Feb 26;14(3):138. doi: 10.3390/metabo14030138. Metabolites. 2024. PMID: 38535298 Free PMC article. - Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives.
Roy S, Dhaneshwar S. Roy S, et al. World J Gastroenterol. 2023 Apr 14;29(14):2078-2100. doi: 10.3748/wjg.v29.i14.2078. World J Gastroenterol. 2023. PMID: 37122604 Free PMC article. Review. - Upregulation of Intestinal Barrier Function in Mice with DSS-Induced Colitis by a Defined Bacterial Consortium Is Associated with Expansion of IL-17A Producing Gamma Delta T Cells.
Li M, Wang B, Sun X, Tang Y, Wei X, Ge B, Tang Y, Deng Y, He C, Yuan J, Li X. Li M, et al. Front Immunol. 2017 Jul 12;8:824. doi: 10.3389/fimmu.2017.00824. eCollection 2017. Front Immunol. 2017. PMID: 28747917 Free PMC article.
References
- J Gastroenterol Hepatol. 2015 Jan;30(1):51-8 - PubMed
- Nature. 2014 May 15;509(7500):357-60 - PubMed
- Nature. 2011 Jun 15;474(7351):307-17 - PubMed
- Genome Biol. 2012 Apr 16;13(9):R79 - PubMed
- Gut Microbes. 2016 May 3;7(3):189-200 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources